v3.26.1
Share-Based Payment - Schedule of Total Equity-Based Compensation Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Schedule of Total Equity-Based Compensation Expense [Line Items]      
Cost of revenues $ 35
Research and development expenses 163 (11) 3,010
Sales and marketing expenses 85 (32) 211
General and administrative expenses 2,941 2,113 3,859
Total share-based payment $ 3,189 $ 2,070 $ 7,115